US Stock MarketDetailed Quotes

SEELQ Seelos Therapeutics

Watchlist
  • 0.320
  • -0.005-1.54%
15min DelayTrading Nov 29 09:30 ET
185.98KMarket Cap0.00P/E (TTM)

Seelos Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
83.54%-972K
55.14%-4.64M
61.18%-23.91M
85.40%-1.91M
48.09%-5.75M
71.05%-5.9M
39.29%-10.35M
-25.74%-61.6M
28.62%-13.09M
-5.37%-11.07M
Net income from continuing operations
105.80%1.71M
80.17%-2.66M
48.48%-37.88M
70.77%-5.45M
153.55%10.5M
-38.66%-29.5M
4.07%-13.43M
-11.33%-73.53M
31.56%-18.66M
-81.27%-19.6M
Operating gains losses
-125.35%-3.47M
-177.99%-3.61M
-2,928.77%-8.84M
-3,165.00%-3.27M
-26,370.33%-23.91M
28,063.27%13.7M
2,076.50%4.63M
-109.35%-292K
-174.63%-100K
219.74%91K
Depreciation and amortization
7.14%15K
7.14%15K
7.55%57K
-71.70%15K
--14K
--14K
--14K
--53K
--53K
--0
Other non cash items
----
----
47.23%6.35M
-29.65%700K
-36.87%1.35M
----
----
-38.29%4.31M
-81.60%995K
11,772.22%2.14M
Change In working capital
-67.19%1.3M
117.87%456K
346.25%12.42M
38.15%5.13M
10.19%5.87M
508.54%3.97M
51.72%-2.55M
297.80%2.78M
256.69%3.71M
1,178.74%5.33M
-Change in receivables
115.47%780K
74.15%-205K
---763K
---542K
--210K
--362K
---793K
--0
--0
--0
-Change in prepaid assets
-93.48%206K
70.41%-414K
353.09%5.69M
-39.11%1.74M
73.57%2.19M
243.96%3.16M
66.43%-1.4M
22.36%-2.25M
530.12%2.86M
224.02%1.26M
-Change in payables and accrued expense
-28.29%332K
414.12%1.09M
20.75%7.55M
335.17%3.95M
-14.23%3.49M
-62.14%463K
-719.64%-347K
320.65%6.26M
153.20%907K
679.50%4.07M
-Change in other current liabilities
-7.14%-15K
-15.38%-15K
95.27%-58K
68.63%-16K
---15K
---14K
98.89%-13K
---1.23M
---51K
--0
Cash from discontinued investing activities
Operating cash flow
83.54%-972K
55.14%-4.64M
61.18%-23.91M
85.40%-1.91M
48.09%-5.75M
71.05%-5.9M
39.29%-10.35M
-25.74%-61.6M
28.62%-13.09M
-5.37%-11.07M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
132.09%742K
-75.55%2.17M
812.27%11.38M
223.04%2.32M
645.51%2.49M
-1,734.92%-2.31M
10,591.57%8.87M
-101.43%-1.6M
-109.33%-1.89M
133.57%334K
Net issuance payments of debt
92.00%-185K
-2.18%-1.31M
-304.71%-7.64M
-14.09%-2.15M
---1.89M
---2.31M
---1.29M
86.07%-1.89M
---1.89M
--0
Net common stock issuance
--927K
-65.54%3.48M
4,039.82%18.92M
--4.48M
850.33%4.34M
--0
--10.1M
-99.61%457K
--0
--457K
Proceeds from stock option exercised by employees
--0
-93.44%4K
-9.35%97K
--0
50.00%36K
--0
-26.51%61K
-98.57%107K
--0
-67.57%24K
Net other financing activities
----
----
----
----
----
----
----
---273K
--0
---147K
Cash from discontinued financing activities
Financing cash flow
132.09%742K
-75.55%2.17M
812.27%11.38M
223.04%2.32M
645.51%2.49M
-1,734.92%-2.31M
10,591.57%8.87M
-101.43%-1.6M
-109.33%-1.89M
133.57%334K
Net cash flow
Beginning cash position
-96.27%524K
-80.71%3M
-80.27%15.53M
-91.53%2.58M
-85.84%5.84M
-77.24%14.06M
-80.27%15.53M
402.71%78.73M
-60.29%30.51M
-52.69%41.25M
Current changes in cash
97.20%-230K
-67.71%-2.47M
80.16%-12.54M
102.75%412K
69.66%-3.26M
59.96%-8.22M
91.31%-1.47M
-200.20%-63.2M
-887.90%-14.98M
-3.60%-10.74M
End cash Position
-94.97%294K
-96.27%524K
-80.71%3M
-80.71%3M
-91.53%2.58M
-85.84%5.84M
-77.24%14.06M
-80.27%15.53M
-80.27%15.53M
-60.29%30.51M
Free cash flow
83.54%-972K
55.14%-4.64M
61.18%-23.91M
85.40%-1.91M
48.09%-5.75M
71.05%-5.9M
39.29%-10.35M
-25.74%-61.6M
28.62%-13.09M
-5.37%-11.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 83.54%-972K55.14%-4.64M61.18%-23.91M85.40%-1.91M48.09%-5.75M71.05%-5.9M39.29%-10.35M-25.74%-61.6M28.62%-13.09M-5.37%-11.07M
Net income from continuing operations 105.80%1.71M80.17%-2.66M48.48%-37.88M70.77%-5.45M153.55%10.5M-38.66%-29.5M4.07%-13.43M-11.33%-73.53M31.56%-18.66M-81.27%-19.6M
Operating gains losses -125.35%-3.47M-177.99%-3.61M-2,928.77%-8.84M-3,165.00%-3.27M-26,370.33%-23.91M28,063.27%13.7M2,076.50%4.63M-109.35%-292K-174.63%-100K219.74%91K
Depreciation and amortization 7.14%15K7.14%15K7.55%57K-71.70%15K--14K--14K--14K--53K--53K--0
Other non cash items --------47.23%6.35M-29.65%700K-36.87%1.35M---------38.29%4.31M-81.60%995K11,772.22%2.14M
Change In working capital -67.19%1.3M117.87%456K346.25%12.42M38.15%5.13M10.19%5.87M508.54%3.97M51.72%-2.55M297.80%2.78M256.69%3.71M1,178.74%5.33M
-Change in receivables 115.47%780K74.15%-205K---763K---542K--210K--362K---793K--0--0--0
-Change in prepaid assets -93.48%206K70.41%-414K353.09%5.69M-39.11%1.74M73.57%2.19M243.96%3.16M66.43%-1.4M22.36%-2.25M530.12%2.86M224.02%1.26M
-Change in payables and accrued expense -28.29%332K414.12%1.09M20.75%7.55M335.17%3.95M-14.23%3.49M-62.14%463K-719.64%-347K320.65%6.26M153.20%907K679.50%4.07M
-Change in other current liabilities -7.14%-15K-15.38%-15K95.27%-58K68.63%-16K---15K---14K98.89%-13K---1.23M---51K--0
Cash from discontinued investing activities
Operating cash flow 83.54%-972K55.14%-4.64M61.18%-23.91M85.40%-1.91M48.09%-5.75M71.05%-5.9M39.29%-10.35M-25.74%-61.6M28.62%-13.09M-5.37%-11.07M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 132.09%742K-75.55%2.17M812.27%11.38M223.04%2.32M645.51%2.49M-1,734.92%-2.31M10,591.57%8.87M-101.43%-1.6M-109.33%-1.89M133.57%334K
Net issuance payments of debt 92.00%-185K-2.18%-1.31M-304.71%-7.64M-14.09%-2.15M---1.89M---2.31M---1.29M86.07%-1.89M---1.89M--0
Net common stock issuance --927K-65.54%3.48M4,039.82%18.92M--4.48M850.33%4.34M--0--10.1M-99.61%457K--0--457K
Proceeds from stock option exercised by employees --0-93.44%4K-9.35%97K--050.00%36K--0-26.51%61K-98.57%107K--0-67.57%24K
Net other financing activities -------------------------------273K--0---147K
Cash from discontinued financing activities
Financing cash flow 132.09%742K-75.55%2.17M812.27%11.38M223.04%2.32M645.51%2.49M-1,734.92%-2.31M10,591.57%8.87M-101.43%-1.6M-109.33%-1.89M133.57%334K
Net cash flow
Beginning cash position -96.27%524K-80.71%3M-80.27%15.53M-91.53%2.58M-85.84%5.84M-77.24%14.06M-80.27%15.53M402.71%78.73M-60.29%30.51M-52.69%41.25M
Current changes in cash 97.20%-230K-67.71%-2.47M80.16%-12.54M102.75%412K69.66%-3.26M59.96%-8.22M91.31%-1.47M-200.20%-63.2M-887.90%-14.98M-3.60%-10.74M
End cash Position -94.97%294K-96.27%524K-80.71%3M-80.71%3M-91.53%2.58M-85.84%5.84M-77.24%14.06M-80.27%15.53M-80.27%15.53M-60.29%30.51M
Free cash flow 83.54%-972K55.14%-4.64M61.18%-23.91M85.40%-1.91M48.09%-5.75M71.05%-5.9M39.29%-10.35M-25.74%-61.6M28.62%-13.09M-5.37%-11.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data